Bridges Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.6M | Buy |
25,479
+523
| +2% | +$534K | 0.37% | 55 |
|
|
2026
Q1 | $23M | Buy |
24,956
+1,134
| +5% | +$1.15M | 0.31% | 67 |
|
|
2025
Q4 | $25.6M | Buy |
23,822
+12,309
| +107% | +$11.8M | 0.32% | 63 |
|
|
2025
Q3 | $8.78M | Buy |
11,513
+466
| +4% | +$347K | 0.11% | 92 |
|
|
2025
Q2 | $8.61M | Buy |
11,047
+123
| +1% | +$95.6K | 0.12% | 93 |
|
|
2025
Q1 | $9.02M | Sell |
10,924
-540
| -5% | -$449K | 0.13% | 92 |
|
|
2024
Q4 | $8.85M | Sell |
11,464
-381
| -3% | -$315K | 0.12% | 92 |
|
|
2024
Q3 | $10.5M | Buy |
11,845
+484
| +4% | +$435K | 0.15% | 89 |
|
|
2024
Q2 | $10.3M | Buy |
11,361
+1,436
| +14% | +$1.15M | 0.16% | 81 |
|
|
2024
Q1 | $7.72M | Sell |
9,925
-42
| -0.4% | -$29.9K | 0.24% | 65 |
|
|
2023
Q4 | $5.81M | Sell |
9,967
-59
| -0.6% | -$34.4K | 0.19% | 70 |
|
|
2023
Q3 | $5.39M | Sell |
10,026
-30
| -0.3% | -$15.5K | 0.19% | 69 |
|
|
2023
Q2 | $4.72M | Sell |
10,056
-58
| -0.6% | -$24.3K | 0.16% | 77 |
|
|
2023
Q1 | $3.47M | Sell |
10,114
-50
| -0.5% | -$16.9K | 0.12% | 85 |
|
|
2022
Q4 | $3.72M | Sell |
10,164
-50
| -0.5% | -$17.7K | 0.14% | 87 |
|
|
2022
Q3 | $3.3M | Sell |
10,214
-449
| -4% | -$142K | 0.13% | 85 |
|
|
2022
Q2 | $3.46M | Hold |
10,663
| – | – | 0.13% | 87 |
|
|
2022
Q1 | $3.05M | Sell |
10,663
-125
| -1% | -$32.2K | 0.09% | 105 |
|
|
2021
Q4 | $2.98M | Buy |
10,788
+75
| +0.7% | +$19K | 0.09% | 104 |
|
|
2021
Q3 | $2.48M | Sell |
10,713
-307
| -3% | -$75.8K | 0.08% | 113 |
|
|
2021
Q2 | $2.53M | Hold |
11,020
| – | – | 0.08% | 111 |
|
|
2021
Q1 | $2.06M | Hold |
11,020
| – | – | 0.06% | 118 |
|
|
2020
Q4 | $1.86M | Sell |
11,020
-20
| -0.2% | -$2.99K | 0.06% | 119 |
|
|
2020
Q3 | $1.63M | Sell |
11,040
-152
| -1% | -$23.5K | 0.06% | 120 |
|
|
2020
Q2 | $1.84M | Buy |
11,192
+107
| +1% | +$16.4K | 0.07% | 113 |
|
|
2020
Q1 | $1.54M | Sell |
11,085
-248
| -2% | -$34.1K | 0.07% | 119 |
|
|
2019
Q4 | $1.49M | Buy |
11,333
+1,500
| +15% | +$174K | 0.06% | 139 |
|
|
2019
Q3 | $1.1M | Sell |
9,833
-500
| -5% | -$55.7K | 0.04% | 190 |
|
|
2019
Q2 | $1.15M | Sell |
10,333
-132
| -1% | -$15.5K | 0.04% | 181 |
|
|
2019
Q1 | $1.36M | Hold |
10,465
| – | – | 0.06% | 165 |
|
|
2018
Q4 | $1.21M | Hold |
10,465
| – | – | 0.06% | 159 |
|
|
2018
Q3 | $1.12M | Sell |
10,465
-1,300
| -11% | -$130K | 0.06% | 162 |
|
|
2018
Q2 | $1M | Buy |
11,765
+2,000
| +20% | +$164K | 0.05% | 170 |
|
|
2018
Q1 | $756K | Buy |
9,765
+6,867
| +237% | +$553K | 0.03% | 172 |
|
|
2017
Q4 | $244K | Buy |
2,898
+400
| +16% | +$34K | 0.02% | 183 |
|
|
2017
Q3 | $214K | Buy |
+2,498
| New | +$205K | 0.02% | 146 |
|
Other funds holding LLY
Bridges Investment Management's LLY Position: Q2 2026 in Review
Bridges Investment Management increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $534K and bringing the position to 25,479 shares worth $30.6M. The position accounts for 0.37% of the portfolio, ranked #55.
Bridges Investment Management first reported a position in LLY in Q3 2017 and has held it in 36 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bridges Investment Management held 25,479 shares of Eli Lilly worth $30.6M as of Q2 2026.
- Bridges Investment Management bought 523 Eli Lilly shares in Q2 2026, an estimated $534K.
- Eli Lilly made up 0.37% of Bridges Investment Management's portfolio in Q2 2026, its #55 holding.
- Bridges Investment Management first reported a position in Eli Lilly in Q3 2017 and has held it in 36 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.